Nebenwirkungen · Pegasys
Pegasys 90 micrograms solution for injection in pre-filled syringe Pegasys 135 micrograms solution for injection in pre-filled syringe Pegasys 180 micrograms solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 21–22
HOS-109839 · Präparat HOS-093265
21 Body system Very Common Uncommon Rare Very rare Frequency common not known General Pyrexia, Chest pain, disorders and rigors*, pain*, influenza like administration asthenia, illness, malaise, site conditions fatigue, lethargy, hot injection site flushes, thirst reaction*, irritability* Investigations Weight decreased Injury, poisoning Substance and procedural overdose complications *These adverse reactions were common (≥1/100 to < 1/10) in CHB patients treated with Pegasys monotherapy § Class label for interferon products, see below Pulmonary arterial hypertension.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-22T12:00:00Z · SHA-256 d1a2dc533bd5ba4d4a21ad6973e4498c4ffde781c784ae67bbeeda36922e6382 · Passage a23aea25f072b53381afeb022c4cb7a3c0ef7317e487cb58506a43eaf162995d · Zeichen 14205–15162 im Abschnitt